Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 842

1.

Emerging drugs for treating methicillin-resistant Staphylococcus aureus.

Bassetti M, Russo A, Carnelutti A, Wilcox M.

Expert Opin Emerg Drugs. 2019 Sep;24(3):191-204. doi: 10.1080/14728214.2019.1677607.

PMID:
31590576
2.

Measuring outcomes in complicated intra-abdominal infections.

Ahmed S, Wilcox M, Kirby A.

Curr Opin Gastroenterol. 2019 Sep 17. doi: 10.1097/MOG.0000000000000591. [Epub ahead of print]

PMID:
31567430
3.

Reply to Tenover et al., "Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides (Clostridium) difficile Infection".

Sandlund J, Wilcox MH.

J Clin Microbiol. 2019 Sep 24;57(10). pii: e01157-19. doi: 10.1128/JCM.01157-19. Print 2019 Oct. No abstract available.

PMID:
31551344
4.

Combating resistance while maintaining innovation: the future of antimicrobial stewardship.

Vickers RJ, Bassetti M, Clancy CJ, Garey KW, Greenberg DE, Nguyen MH, Roblin D, Tillotson GS, Wilcox MH.

Future Microbiol. 2019 Sep 17. doi: 10.2217/fmb-2019-0227. [Epub ahead of print]

5.

Effects of Consuming Almonds on Insulin Sensitivity and Other Cardiometabolic Health Markers in Adults With Prediabetes.

Palacios OM, Maki KC, Xiao D, Wilcox ML, Dicklin MR, Kramer M, Trivedi R, Burton-Freeman B, Edirisinghe I.

J Am Coll Nutr. 2019 Sep 16:1-10. doi: 10.1080/07315724.2019.1660929. [Epub ahead of print]

PMID:
31525129
6.

Actigraphic measures of sleep on the wards after ICU discharge.

Wilcox ME, Rubenfeld GD, Walczak KD, Black SE, McAndrews MP, Lim AS.

J Crit Care. 2019 Aug 16;54:163-169. doi: 10.1016/j.jcrc.2019.08.006. [Epub ahead of print]

PMID:
31472397
7.

Investigating the transient and persistent effects of heat on Clostridium difficile spores.

Pickering DS, Vernon JJ, Freeman J, Wilcox MH, Chilton CH.

J Med Microbiol. 2019 Oct;68(10):1445-1454. doi: 10.1099/jmm.0.001048. Epub 2019 Aug 8.

8.

Multi-Tuned Cable Traps for Multinuclear MRI and MRS.

Wilcox M, Wright SM, McDougall MP.

IEEE Trans Biomed Eng. 2019 Aug 7. doi: 10.1109/TBME.2019.2933733. [Epub ahead of print]

PMID:
31398104
9.

Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II.

Wilcox MH, Rahav G, Dubberke ER, Gabryelski L, Davies K, Berry C, Eves K, Ellison MC, Guris D, Dorr MB.

Open Forum Infect Dis. 2019 Aug 1;6(8). pii: ofz293. doi: 10.1093/ofid/ofz293.

10.

A two-step approach for the investigation of a Clostridium difficile outbreak by molecular methods.

Krutova M, Wilcox MH, Kuijper EJ.

Clin Microbiol Infect. 2019 Jul 29. pii: S1198-743X(19)30414-8. doi: 10.1016/j.cmi.2019.07.022. [Epub ahead of print] No abstract available.

PMID:
31369805
11.

Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: being AWaRe.

Budd E, Cramp E, Sharland M, Hand K, Howard P, Wilson P, Wilcox M, Muller-Pebody B, Hopkins S.

J Antimicrob Chemother. 2019 Nov 1;74(11):3384-3389. doi: 10.1093/jac/dkz321.

12.

Challenges in conducting long-term outcomes studies in critical care.

Wilcox ME, Ely EW.

Curr Opin Crit Care. 2019 Oct;25(5):473-488. doi: 10.1097/MCC.0000000000000650.

PMID:
31356238
13.

An assessment of fatigability following nerve transfer to reinnervate elbow flexor muscles.

Wilcox M, Brown H, Johnson K, Sinisi M, Quick TJ.

Bone Joint J. 2019 Jul;101-B(7):867-871. doi: 10.1302/0301-620X.101B7.BJJ-2019-0005.R1.

PMID:
31256676
14.

The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials.

Kong LY, Davies K, Wilcox MH.

Anaerobe. 2019 Jun 12. pii: S1075-9964(19)30098-8. doi: 10.1016/j.anaerobe.2019.06.001. [Epub ahead of print]

PMID:
31201853
15.

The Effects of Surgical Antiseptics and Time Delays on RNA Isolated From Human and Rodent Peripheral Nerves.

Wilcox M, Quick TJ, Phillips JB.

Front Cell Neurosci. 2019 May 22;13:189. doi: 10.3389/fncel.2019.00189. eCollection 2019.

16.

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.

Earl HM, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Harnett AN, Ah-See ML, Simcock R, Rea D, Raj S, Woodings P, Harries M, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mansi J, Gounaris I, Mahler-Araujo B, Provenzano E, Chhabra A, Abraham JE, Caldas C, Hall PS, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA; PERSEPHONE Steering Committee and Trial Investigators.

Lancet. 2019 Jun 29;393(10191):2599-2612. doi: 10.1016/S0140-6736(19)30650-6. Epub 2019 Jun 6.

17.

The SMALL Trial: A Big Change for Small Breast Cancers.

Morgan J, Potter S, Sharma N, McIntosh SA; SMALL Trial Management Group, Coles CE, Dodwell D, Elder K, Gaunt C, Lyburn ID, McIntosh SA, Morgan J, Paramasivan S, Pinder S, Pirrie S, Potter S, Rea D, Roberts T, Sharma N, Stobart H, Taylor-Phillips S, Wallis M, Wilcox M.

Clin Oncol (R Coll Radiol). 2019 Sep;31(9):659-663. doi: 10.1016/j.clon.2019.05.008. Epub 2019 May 31. No abstract available.

PMID:
31160130
18.

Use of Antiepileptic Drugs in Aneurysmal Subarachnoid Hemorrhage.

Dmytriw AA, Maragkos GA, Zuccato J, Singh JM, Wilcox ME, Schweikert S.

Can J Neurol Sci. 2019 Jul;46(4):423-429. doi: 10.1017/cjn.2019.54. Epub 2019 May 22.

PMID:
31113497
19.

Serum IgE and IgG reactivity to Aspergillus recombinant antigens in patients with cystic fibrosis.

Alghamdi NS, Barton R, Wilcox M, Peckham D.

J Med Microbiol. 2019 Jun;68(6):924-929. doi: 10.1099/jmm.0.000991. Epub 2019 May 15.

20.

Valuing antibiotics: The role of the hospital clinician.

Masterton RG, Bassetti M, Chastre J, MacDonald AG, Rello J, Seaton RA, Welte T, Wilcox MH, West P.

Int J Antimicrob Agents. 2019 Jul;54(1):16-22. doi: 10.1016/j.ijantimicag.2019.05.012. Epub 2019 May 11.

PMID:
31085298
21.

Cross-sectional study of the prevalence, causes and management of hospital-onset diarrhoea.

Mawer D, Byrne F, Drake S, Brown C, Prescott A, Warne B, Bousfield R, Skittrall JP, Ramsay I, Somasunderam D, Bevan M, Coslett J, Rao J, Stanley P, Kennedy A, Dobson R, Long S, Obisanya T, Esmailji T, Petridou C, Saeed K, Brechany K, Davis-Blue K, O'Horan H, Wake B, Martin J, Featherstone J, Hall C, Allen J, Johnson G, Hornigold C, Amir N, Henderson K, McClements C, Liew I, Deshpande A, Vink E, Trigg D, Guilfoyle J, Scarborough M, Scarborough C, Wong THN, Walker T, Fawcett N, Morris G, Tomlin K, Grix C, O'Cofaigh E, McCaffrey D, Cooper M, Corbett K, French K, Harper S, Hayward C, Reid M, Whatley V, Winfield J, Hoque S, Kelly L, King I, Bradley A, McCullagh B, Hibberd C, Merron M, McCabe C, Horridge S, Taylor J, Koo S, Elsanousi F, Saunders R, Lim F, Bond A, Stone S, Milligan ID, Mack DJF, Nagar A, West RM, Wilcox MH, Kirby A, Sandoe JAT.

J Hosp Infect. 2019 Oct;103(2):200-209. doi: 10.1016/j.jhin.2019.05.001. Epub 2019 May 8.

PMID:
31077777
22.

Medical education and certification are different things.

Wilcox M.

BMJ. 2019 May 9;365:l1977. doi: 10.1136/bmj.l1977. No abstract available.

PMID:
31072812
23.

Service evaluation of alcohol-release door plates: an addition to hand hygiene.

Wilcox MH, Dyche A.

J Hosp Infect. 2019 Sep;103(1):e97-e100. doi: 10.1016/j.jhin.2019.04.023. Epub 2019 May 7.

PMID:
31071383
24.

Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage.

Eyre DW, Didelot X, Buckley AM, Freeman J, Moura IB, Crook DW, Peto TEA, Walker AS, Wilcox MH, Dingle KE.

EBioMedicine. 2019 May;43:347-355. doi: 10.1016/j.ebiom.2019.04.038. Epub 2019 Apr 27.

25.

A Review of Mixed Strain Clostridium difficile Colonization and Infection.

Dayananda P, Wilcox MH.

Front Microbiol. 2019 Apr 10;10:692. doi: 10.3389/fmicb.2019.00692. eCollection 2019. Review.

26.

'The method used to dry washed hands affects the number and type of transient and residential bacteria remaining on the skin'.

Redway K, Barbut F, Wilcox MH.

J Hosp Infect. 2019 Aug;102(4):473-474. doi: 10.1016/j.jhin.2019.04.006. Epub 2019 Apr 13. No abstract available.

PMID:
30991082
27.

Dissemination of multiple carbapenem resistance genes in an in vitro gut model simulating the human colon.

Rooney CM, Sheppard AE, Clark E, Davies K, Hubbard ATM, Sebra R, Crook DW, Walker AS, Wilcox MH, Chilton CH.

J Antimicrob Chemother. 2019 Jul 1;74(7):1876-1883. doi: 10.1093/jac/dkz106.

PMID:
30989197
28.

Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.

Lv X, Alder J, Li L, O'Riordan W, Rybak MJ, Ye H, Zhang R, Zhang Z, Zhu X, Wilcox MH.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e02252-18. doi: 10.1128/AAC.02252-18. Print 2019 Jul.

29.

Cost-Effectiveness Studies in the ICU: A Systematic Review.

Wilcox ME, Vaughan K, Chong CAKY, Neumann PJ, Bell CM.

Crit Care Med. 2019 Aug;47(8):1011-1017. doi: 10.1097/CCM.0000000000003768.

PMID:
30985446
30.

Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease.

Dettmar PW, Woodcock AD, Wilcox MD, Chater PI, Pearson JP.

Aliment Pharmacol Ther. 2019 May;49(9):1248-1249. doi: 10.1111/apt.15213. No abstract available.

31.

Ultrasensitive Detection of Clostridium difficile Toxins Reveals Suboptimal Accuracy of Toxin Gene Cycle Thresholds for Toxin Predictions.

Sandlund J, Wilcox MH.

J Clin Microbiol. 2019 May 24;57(6). pii: e01885-18. doi: 10.1128/JCM.01885-18. Print 2019 Jun.

32.

A Role for Tetracycline Selection in Recent Evolution of Agriculture-Associated Clostridium difficile PCR Ribotype 078.

Dingle KE, Didelot X, Quan TP, Eyre DW, Stoesser N, Marwick CA, Coia J, Brown D, Buchanan S, Ijaz UZ, Goswami C, Douce G, Fawley WN, Wilcox MH, Peto TEA, Walker AS, Crook DW.

MBio. 2019 Mar 12;10(2). pii: e02790-18. doi: 10.1128/mBio.02790-18.

33.

Sleep and Circadian Rhythm in Critical Illness.

Telias I, Wilcox ME.

Crit Care. 2019 Mar 9;23(1):82. doi: 10.1186/s13054-019-2366-0. Review.

34.

Risperdal® CONSTA® Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans Affairs.

Wilcox MA, Coppola D, Bailey N, Wilson A, Kamauu AWC, Alba PR, Patterson OV, Viernes B, Denhalter DW, Solomon ID, DuVall SL.

Neurol Ther. 2019 Jun;8(1):95-108. doi: 10.1007/s40120-019-0130-7. Epub 2019 Mar 7.

35.

Sleep and Pathological Wakefulness at the Time of Liberation from Mechanical Ventilation (SLEEWE). A Prospective Multicenter Physiological Study.

Dres M, Younes M, Rittayamai N, Kendzerska T, Telias I, Grieco DL, Pham T, Junhasavasdikul D, Chau E, Mehta S, Wilcox ME, Leung R, Drouot X, Brochard L.

Am J Respir Crit Care Med. 2019 May 1;199(9):1106-1115. doi: 10.1164/rccm.201811-2119OC.

PMID:
30818966
36.

Encapsulation of stevia rebaudiana Bertoni aqueous crude extracts by ionic gelation - Effects of alginate blends and gelling solutions on the polyphenolic profile.

Arriola NDA, Chater PI, Wilcox M, Lucini L, Rocchetti G, Dalmina M, Pearson JP, de Mello Castanho Amboni RD.

Food Chem. 2019 Mar 1;275:123-134. doi: 10.1016/j.foodchem.2018.09.086. Epub 2018 Sep 14.

PMID:
30724178
37.

Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group.

Wilcox M, Al-Obeid S, Gales A, Kozlov R, Martínez-Orozco JA, Rossi F, Sidorenko S, Blondeau J.

Future Microbiol. 2019 Mar;14:345-352. doi: 10.2217/fmb-2018-0346. Epub 2019 Feb 6.

38.

Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.

Corey GR, Wilcox MH, Gonzalez J, Jandourek A, Wilson DJ, Friedland HD, Das S, Iaconis J, Dryden M.

Int J Antimicrob Agents. 2019 Jun;53(6):830-837. doi: 10.1016/j.ijantimicag.2019.01.016. Epub 2019 Feb 1.

39.

Corrigendum to "Environmental contamination by bacteria in hospital washrooms according to hand-drying method: a multi-centre study" [J Hospital Infection 100 (2018) 469-475].

Best E, Parnell P, Couturier J, Barbut F, Le Bozec A, Arnoldo L, Madia A, Brusaferro S, Wilcox MH.

J Hosp Infect. 2019 Apr;101(4):487. doi: 10.1016/j.jhin.2019.01.014. Epub 2019 Jan 31. No abstract available.

40.

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.

Gerding DN, Cornely OA, Grill S, Kracker H, Marrast AC, Nord CE, Talbot GH, Buitrago M, Gheorghe Diaconescu I, Murta de Oliveira C, Preotescu L, Pullman J, Louie TJ, Wilcox MH.

Lancet Infect Dis. 2019 Mar;19(3):265-274. doi: 10.1016/S1473-3099(18)30614-5. Epub 2019 Jan 29.

41.

Molecular epidemiology of Clostridioides (previously Clostridium) difficile isolates from a university hospital in Minas Gerais, Brazil.

Diniz AN, de Oliveira Júnior CA, Vilela EG, Figueiredo HCP, Rupnik M, Wilcox MH, Fawley WN, Blanc DS, Faria Lobato FC, Silva ROS.

Anaerobe. 2019 Apr;56:34-39. doi: 10.1016/j.anaerobe.2019.01.010. Epub 2019 Jan 29.

PMID:
30703440
42.

Building new twenty-first century medical school libraries from the ground up: challenges, experiences, and lessons learned.

Dexter N, Muellenbach JM, Lorbeer ER, Rand D, Wilcox ME, Long BA.

J Med Libr Assoc. 2019 Jan;107(1):6-15. doi: 10.5195/jmla.2019.493. Epub 2019 Jan 1.

43.

Effect of fluoroquinolone resistance mutation Thr-82→Ile on Clostridioides difficile fitness.

Vernon JJ, Wilcox MH, Freeman J.

J Antimicrob Chemother. 2019 Apr 1;74(4):877-884. doi: 10.1093/jac/dky535.

PMID:
30590496
44.

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.

Johnston S, Puhalla S, Wheatley D, Ring A, Barry P, Holcombe C, Boileau JF, Provencher L, Robidoux A, Rimawi M, McIntosh SA, Shalaby I, Stein RC, Thirlwell M, Dolling D, Morden J, Snowdon C, Perry S, Cornman C, Batten LM, Jeffs LK, Dodson A, Martins V, Modi A, Osborne CK, Pogue-Geile KL, Cheang MCU, Wolmark N, Julian TB, Fisher K, MacKenzie M, Wilcox M, Huang Bartlett C, Koehler M, Dowsett M, Bliss JM, Jacobs SA.

J Clin Oncol. 2019 Jan 20;37(3):178-189. doi: 10.1200/JCO.18.01624. Epub 2018 Dec 6.

PMID:
30523750
45.

The predictive value of quantitative nucleic acid amplification detection of Clostridium difficile toxin gene for faecal sample toxin status and patient outcome.

Davies KA, Planche T, Wilcox MH.

PLoS One. 2018 Dec 5;13(12):e0205941. doi: 10.1371/journal.pone.0205941. eCollection 2018.

46.

The effect of thiamine-coating nanoparticles on their biodistribution and fate following oral administration.

Inchaurraga L, Martínez-López AL, Cattoz B, Griffiths PC, Wilcox M, Pearson JP, Quincoces G, Peñuelas I, Martin-Arbella N, Irache JM.

Eur J Pharm Sci. 2019 Feb 1;128:81-90. doi: 10.1016/j.ejps.2018.11.025. Epub 2018 Nov 23.

PMID:
30472222
47.

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics.

Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH.

Infect Drug Resist. 2018 Oct 25;11:1959-1974. doi: 10.2147/IDR.S172366. eCollection 2018. Review.

48.

Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon.

Moura IB, Buckley AM, Ewin D, Shearman S, Clark E, Wilcox MH, Chilton CH.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01581-18. doi: 10.1128/AAC.01581-18. Print 2019 Feb.

49.

Double-Tuned Cable Traps For Multinuclear MRI And MRS.

Wilcox M, McDougall M.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:1364-1367. doi: 10.1109/EMBC.2018.8512474.

PMID:
30440645
50.

Models of Peer Support to Remediate Post-Intensive Care Syndrome: A Report Developed by the Society of Critical Care Medicine Thrive International Peer Support Collaborative.

McPeake J, Hirshberg EL, Christie LM, Drumright K, Haines K, Hough CL, Meyer J, Wade D, Andrews A, Bakhru R, Bates S, Barwise JA, Bastarache J, Beesley SJ, Boehm LM, Brown S, Clay AS, Firshman P, Greenberg S, Harris W, Hill C, Hodgson C, Holdsworth C, Hope AA, Hopkins RO, Howell DCJ, Janssen A, Jackson JC, Johnson A, Kross EK, Lamas D, MacLeod-Smith B, Mandel R, Marshall J, Mikkelsen ME, Nackino M, Quasim T, Sevin CM, Slack A, Spurr R, Still M, Thompson C, Weinhouse G, Wilcox ME, Iwashyna TJ.

Crit Care Med. 2019 Jan;47(1):e21-e27. doi: 10.1097/CCM.0000000000003497.

Supplemental Content

Loading ...
Support Center